JP2009522292A5 - - Google Patents

Download PDF

Info

Publication number
JP2009522292A5
JP2009522292A5 JP2008548751A JP2008548751A JP2009522292A5 JP 2009522292 A5 JP2009522292 A5 JP 2009522292A5 JP 2008548751 A JP2008548751 A JP 2008548751A JP 2008548751 A JP2008548751 A JP 2008548751A JP 2009522292 A5 JP2009522292 A5 JP 2009522292A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally
substituted
halogens
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008548751A
Other languages
English (en)
Japanese (ja)
Other versions
JP5192392B2 (ja
JP2009522292A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/049504 external-priority patent/WO2007081570A2/en
Publication of JP2009522292A publication Critical patent/JP2009522292A/ja
Publication of JP2009522292A5 publication Critical patent/JP2009522292A5/ja
Application granted granted Critical
Publication of JP5192392B2 publication Critical patent/JP5192392B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008548751A 2005-12-30 2006-12-29 コレステリルエステル転送タンパク質阻害剤 Expired - Fee Related JP5192392B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75520105P 2005-12-30 2005-12-30
US60/755,201 2005-12-30
PCT/US2006/049504 WO2007081570A2 (en) 2005-12-30 2006-12-29 Cholesteryl ester transfer protein inhibitors

Publications (3)

Publication Number Publication Date
JP2009522292A JP2009522292A (ja) 2009-06-11
JP2009522292A5 true JP2009522292A5 (cg-RX-API-DMAC7.html) 2010-02-12
JP5192392B2 JP5192392B2 (ja) 2013-05-08

Family

ID=38256810

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008548751A Expired - Fee Related JP5192392B2 (ja) 2005-12-30 2006-12-29 コレステリルエステル転送タンパク質阻害剤

Country Status (6)

Country Link
US (1) US8865707B2 (cg-RX-API-DMAC7.html)
EP (1) EP1973546B1 (cg-RX-API-DMAC7.html)
JP (1) JP5192392B2 (cg-RX-API-DMAC7.html)
AU (1) AU2006335109B2 (cg-RX-API-DMAC7.html)
CA (1) CA2635087A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007081570A2 (cg-RX-API-DMAC7.html)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8835426B2 (en) * 2007-02-26 2014-09-16 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1
GB0722769D0 (en) * 2007-11-21 2008-01-02 Biolipox Ab New compounds
AR065709A1 (es) * 2007-03-12 2009-06-24 Biolipox Ab Piperidinonas y composiciones farmaceuticas que las contienen usadas para el tratamiento de la inflamacion. procesos de obtencion.
JP5451611B2 (ja) * 2007-07-26 2014-03-26 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1のサイクリックインヒビター
CN101412711A (zh) * 2007-10-15 2009-04-22 上海恒瑞医药有限公司 氨基甲酸酯类衍生物及其在医药上的应用
AR069207A1 (es) * 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
US8859580B2 (en) 2007-11-16 2014-10-14 Boehringer Ingelheim International Gmbh Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
CA2708303A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
TW200934490A (en) * 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
WO2009094169A1 (en) * 2008-01-24 2009-07-30 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2714532A1 (en) * 2008-02-11 2009-08-20 Vitae Pharmaceuticals, Inc. 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
EP2257536A4 (en) 2008-02-14 2011-03-23 Amira Pharmaceuticals Inc CYCLIC DIARYL ETHERS AS ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
US8598160B2 (en) * 2008-02-15 2013-12-03 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
US8497381B2 (en) 2008-02-25 2013-07-30 Panmira Pharmaceuticals, Llc Antagonists of prostaglandin D2 receptors
CA2718264A1 (en) * 2008-03-18 2009-09-24 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
US8426449B2 (en) 2008-04-02 2013-04-23 Panmira Pharmaceuticals, Llc Aminoalkylphenyl antagonists of prostaglandin D2 receptors
KR20110002492A (ko) 2008-05-01 2011-01-07 비타이 파마슈티컬즈, 인코포레이티드 11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
EP2291370B1 (en) 2008-05-01 2013-11-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TW201004945A (en) * 2008-05-01 2010-02-01 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2723032A1 (en) * 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8765780B2 (en) 2008-05-13 2014-07-01 Boehringer Ingelheim International Gmbh Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
CA2729993A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
WO2010011314A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
US8846668B2 (en) 2008-07-25 2014-09-30 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8383654B2 (en) 2008-11-17 2013-02-26 Panmira Pharmaceuticals, Llc Heterocyclic antagonists of prostaglandin D2 receptors
JP5679997B2 (ja) * 2009-02-04 2015-03-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
TW201039034A (en) * 2009-04-27 2010-11-01 Chunghwa Picture Tubes Ltd Pixel structure and the method of forming the same
KR20120061771A (ko) * 2009-04-30 2012-06-13 비타이 파마슈티컬즈, 인코포레이티드 11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
UA109255C2 (ru) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
WO2011011123A1 (en) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
WO2010148179A1 (en) * 2009-06-18 2010-12-23 Japan Tobacco Inc. Method of treating a disorder associated with mtp
WO2011002910A1 (en) 2009-07-01 2011-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2496589B1 (en) 2009-11-05 2014-03-05 Boehringer Ingelheim International GmbH Novel chiral phosphorus ligands
AR078887A1 (es) 2009-11-06 2011-12-07 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina y composiciones farmaceuticas que los contienen.
WO2011114103A1 (en) 2010-03-18 2011-09-22 Biolipox Ab Pyrimidinones for use as medicaments
EP2576570A1 (en) 2010-05-26 2013-04-10 Boehringer Ingelheim International GmbH 2-oxo-1,2-dihydropyridin-4-ylboronic acid derivatives
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
WO2011161128A1 (en) 2010-06-25 2011-12-29 Boehringer Ingelheim International Gmbh Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
CA2813671A1 (en) 2010-11-02 2012-05-10 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of metabolic disorders
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
PH12013501829A1 (en) * 2011-04-12 2015-10-23 Chong Kun Dang Pharmaceutical Corp Cycloalkenyl aryl derivatives for cetp inhibitor
CN103570499B (zh) * 2011-08-02 2016-04-13 浙江永太科技股份有限公司 一种2-卤代-5-三氟甲基苄醇化合物的制备方法
CN102372605B (zh) * 2011-08-02 2014-03-05 浙江永太科技股份有限公司 一种2-卤代-5-三氟甲基苄醇化合物的制备方法
US8735585B2 (en) 2011-08-17 2014-05-27 Boehringer Ingelheim International Gmbh Indenopyridine derivatives
EP2934518B1 (en) 2012-12-19 2020-02-19 Merck Sharp & Dohme Corp. Spirocyclic cetp inhibitors
WO2014099834A1 (en) 2012-12-20 2014-06-26 Merck Sharp & Dohme Corp. Therapeutic thiazolidinone compounds
EP3027619B1 (en) 2013-07-30 2019-01-02 Merck Sharp & Dohme Corp. Bicyclic ureas and thiadiazolidine-1,1-dioxides as cetp inhibitors
US9688630B2 (en) 2013-10-10 2017-06-27 Merck Sharp & Dohme Corp. 3,3′-disubstituted indolines as inhibitors of cholesterol ester transfer protein
US9663534B2 (en) 2013-12-17 2017-05-30 Merck Sharp & Dohme Corp. Fused bicyclic isoxazolines as inhibitors of cholesterol ester transfer protein
EP3174537B1 (en) 2014-07-29 2021-06-23 Merck Sharp & Dohme Corp. Monocyclic isoxazolines as inhibitors of cholesterol ester transfer protein
US10336730B2 (en) 2015-08-05 2019-07-02 Bristol-Myers Squibb Company Substituted glycine derived FXIA inhibitors
CN106117255A (zh) * 2016-06-20 2016-11-16 许昌豪丰化学科技有限公司 一种苯硼酸的反应液的制取工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776959A (en) * 1995-06-05 1998-07-07 Washington University Anticonvulsant and anxiolytic lactam and thiolactam derivatives
CA2262502C (en) * 1996-07-31 2002-11-26 Nikken Chemicals Co., Ltd. 6-phenyltetrahydro-1,3-oxazin-2-one derivatives and pharmaceutical composition containing the same
DE19741400A1 (de) * 1997-09-19 1999-03-25 Bayer Ag Benzyl-biphenyle
DE69911058T2 (de) 1998-12-23 2004-06-03 G.D. Searle Llc, Chicago Kombinationen einem ibat inhibitor und einem mtp inhibitor für kardiovaskuläre indikationen
WO2001054694A1 (en) * 2000-01-28 2001-08-02 Bristol-Myers Squibb Company Tetrahydropyrimidone inhibitors of fatty acid binding protein and method
JP2002187880A (ja) * 2000-09-27 2002-07-05 Toray Ind Inc 含窒素化合物及びそれを有効成分とするccr3阻害薬
DOP2005000123A (es) 2004-07-02 2011-07-15 Merck Sharp & Dohme Inhibidores de cetp

Similar Documents

Publication Publication Date Title
JP2009537524A5 (cg-RX-API-DMAC7.html)
JP2006500384A5 (cg-RX-API-DMAC7.html)
JP2004536115A5 (cg-RX-API-DMAC7.html)
JP2008505120A5 (cg-RX-API-DMAC7.html)
RU2422450C2 (ru) Новые фосфорсодержащие тиромиметики
RU2345077C2 (ru) ПРОИЗВОДНЫЕ ПИРИДИНО[2,3-d]ПИРИМИДИНА В КАЧЕСТВЕ СЕЛЕКТИВНЫХ ИНГИБИТОРОВ KDR И FGFR
RU2005138134A (ru) Получение и применение арилалкильных производных кислот для лечения ожирения
HRP20161631T1 (hr) Dihidropirazolni gpr40 modulatori
KR940005566A (ko) 퀴놀린 화합물
JP2003523336A5 (cg-RX-API-DMAC7.html)
US9511060B2 (en) Non-flushing niacin analogues, and methods of use thereof
JP2010529203A5 (cg-RX-API-DMAC7.html)
RU2005113713A (ru) Замещенные (тиазол-2-ил)амиды или сульфонамиды в качестве активаторов глюкокиназы, которые могут применяться при лечении диабета типа 2
CA2440037A1 (en) Benzimidazole derivatives for modulating the rage receptor
JP2004506718A5 (cg-RX-API-DMAC7.html)
EA200000155A2 (ru) 4-фенилпиридиновые производные
JP2006522813A5 (cg-RX-API-DMAC7.html)
JP2005502600A5 (cg-RX-API-DMAC7.html)
JP2011509309A5 (cg-RX-API-DMAC7.html)
RU2007148994A (ru) Композиции и способы лечения заболевания сетчатки
RU2009136263A (ru) Производные бензимидазола и способы их применения
RU2009132092A (ru) Конденсированные ароматические дифторметанфосфонаты в качестве ингибиторов протеинтирозинфосфатазы ib (ptp -1b)
KR890008104A (ko) 디아릴스티릴퀴놀린 이산
JP2006520755A5 (cg-RX-API-DMAC7.html)
JP2010516701A5 (cg-RX-API-DMAC7.html)